First Light Asset Management as of March 31, 2017
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 52 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| NeoGenomics (NEO) | 8.0 | $21M | 2.7M | 7.89 | |
| Akorn | 7.1 | $19M | 776k | 24.08 | |
| AtriCure (ATRC) | 7.0 | $18M | 957k | 19.15 | |
| Immunomedics | 5.2 | $14M | 2.1M | 6.47 | |
| Intersect Ent | 4.4 | $11M | 668k | 17.15 | |
| Shire | 3.7 | $9.7M | 56k | 174.24 | |
| Oxford Immunotec Global | 3.7 | $9.6M | 622k | 15.49 | |
| Enzo Biochem (ENZ) | 3.6 | $9.4M | 1.1M | 8.37 | |
| Harvard Bioscience (HBIO) | 3.2 | $8.3M | 3.2M | 2.60 | |
| HealthStream (HSTM) | 2.9 | $7.5M | 310k | 24.23 | |
| Teligent | 2.8 | $7.4M | 949k | 7.81 | |
| LHC | 2.6 | $6.8M | 126k | 53.90 | |
| Medicines Company | 2.5 | $6.7M | 137k | 48.90 | |
| Sage Therapeutics (SAGE) | 2.5 | $6.6M | 94k | 71.07 | |
| Ligand Pharmaceuticals In (LGND) | 2.5 | $6.6M | 63k | 105.84 | |
| Veracyte (VCYT) | 2.5 | $6.6M | 721k | 9.18 | |
| Entellus Medical Cm | 2.1 | $5.6M | 408k | 13.80 | |
| K2m Group Holdings | 2.1 | $5.6M | 272k | 20.51 | |
| Omnicell (OMCL) | 2.1 | $5.4M | 134k | 40.65 | |
| Heron Therapeutics (HRTX) | 2.1 | $5.5M | 364k | 15.00 | |
| Halozyme Therapeutics (HALO) | 2.0 | $5.4M | 415k | 12.96 | |
| Spectranetics Corporation | 2.0 | $5.3M | 182k | 29.12 | |
| Nektar Therapeutics (NKTR) | 2.0 | $5.2M | 223k | 23.47 | |
| Array BioPharma | 1.9 | $5.1M | 566k | 8.94 | |
| Amedisys (AMED) | 1.8 | $4.7M | 93k | 51.09 | |
| NxStage Medical | 1.7 | $4.6M | 170k | 26.83 | |
| Bluebird Bio (BLUE) | 1.7 | $4.5M | 49k | 90.91 | |
| Model N (MODN) | 1.7 | $4.4M | 421k | 10.45 | |
| Bio-techne Corporation (TECH) | 1.5 | $3.9M | 38k | 101.64 | |
| BioMarin Pharmaceutical (BMRN) | 1.1 | $2.8M | 32k | 87.78 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.0 | $2.5M | 23k | 109.36 | |
| Nanostring Technologies (NSTGQ) | 0.9 | $2.3M | 115k | 19.87 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.8 | $2.1M | 7.1k | 293.36 | |
| Ionis Pharmaceuticals (IONS) | 0.8 | $2.0M | 50k | 40.21 | |
| Alkermes (ALKS) | 0.7 | $1.7M | 30k | 58.51 | |
| Celgene Corporation | 0.7 | $1.7M | 14k | 124.44 | |
| Quidel Corporation | 0.6 | $1.7M | 74k | 22.64 | |
| Streamline Health Solutions (STRM) | 0.6 | $1.7M | 1.6M | 1.02 | |
| Powershares Etf Tr Ii s^p smcp hc po | 0.5 | $1.4M | 17k | 80.01 | |
| Health Care SPDR (XLV) | 0.5 | $1.4M | 18k | 74.34 | |
| Tearlab | 0.5 | $1.2M | 421k | 2.84 | |
| iShares Dow Jones US Medical Dev. (IHI) | 0.4 | $1.1M | 7.6k | 151.45 | |
| Macrogenics (MGNX) | 0.4 | $1.1M | 62k | 18.60 | |
| LeMaitre Vascular (LMAT) | 0.4 | $1.1M | 46k | 24.63 | |
| SPDR S&P Biotech (XBI) | 0.2 | $659k | 9.5k | 69.38 | |
| Sanofi-Aventis SA (SNY) | 0.1 | $304k | 6.7k | 45.24 | |
| Pfizer (PFE) | 0.1 | $293k | 8.6k | 34.24 | |
| Chembio Diagnostics | 0.1 | $294k | 56k | 5.30 | |
| Johnson & Johnson (JNJ) | 0.1 | $272k | 2.2k | 124.60 | |
| Novartis (NVS) | 0.1 | $265k | 3.6k | 74.19 | |
| Merck & Co (MRK) | 0.1 | $273k | 4.3k | 63.58 | |
| Abbvie (ABBV) | 0.1 | $271k | 4.2k | 65.16 |
